
PSTV Valuation
Plus Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
PSTV Relative Valuation
PSTV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PSTV is overvalued; if below, it's undervalued.
Historical Valuation
Plus Therapeutics Inc (PSTV) is now in the Overvalued zone, suggesting that its current forward PS ratio of 5.53 is considered Overvalued compared with the five-year average of -1.97. The fair price of Plus Therapeutics Inc (PSTV) is between 0.12 to 0.38 according to relative valuation methord. Compared to the current price of 0.53 USD , Plus Therapeutics Inc is Overvalued By 39.26%.
Relative Value
Fair Zone
0.12-0.38
Current Price:0.53
39.26%
Overvalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-0.38
P/B
Median3y
0.05
Median5y
1.12
-34.15
FCF Yield
Median3y
-150.45
Median5y
-110.81
Competitors Valuation Multiple
The average P/S ratio for PSTV's competitors is 4.15, providing a benchmark for relative valuation. Plus Therapeutics Inc Corp (PSTV) exhibits a P/S ratio of 5.53, which is 33.16% above the industry average. Given its robust revenue growth of -36.85%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

RKDA
Arcadia Biosciences Inc
4.280
USD
+2.15%

JWEL
Jowell Global Ltd
2.203
USD
+0.05%

BGLC
BioNexus Gene Lab Corp
4.900
USD
+0.41%

EFOI
Energy Focus Inc
2.170
USD
-1.81%

HYZN
Hyzon Motors Inc
0.640
USD
0.00%

ANTE
Airnet Technology Inc
1.391
USD
+1.90%

VIRX
Viracta Therapeutics Inc
0.078
USD
0.00%

IMCC
IM Cannabis Corp
2.810
USD
-2.09%

MRIN
Marin Software Inc
0
USD
+4.23%

GLTO
Galecto Inc
3.750
USD
-1.37%
FAQ

Is Plus Therapeutics Inc (PSTV) currently overvalued or undervalued?
Plus Therapeutics Inc (PSTV) is now in the Overvalued zone, suggesting that its current forward PS ratio of 5.53 is considered Overvalued compared with the five-year average of -1.97. The fair price of Plus Therapeutics Inc (PSTV) is between 0.12 to 0.38 according to relative valuation methord. Compared to the current price of 0.53 USD , Plus Therapeutics Inc is Overvalued By 39.26% .

What is Plus Therapeutics Inc (PSTV) fair value?

How does PSTV's valuation metrics compare to the industry average?

What is the current P/B ratio for Plus Therapeutics Inc (PSTV) as of Jul 28 2025?

What is the current FCF Yield for Plus Therapeutics Inc (PSTV) as of Jul 28 2025?

What is the current Forward P/E ratio for Plus Therapeutics Inc (PSTV) as of Jul 28 2025?
